Schedule 13G ownership disclosure

Corbus Pharmaceuticals Holdings, Inc.

Security class unavailable · CUSIP: 21833P103

Event date: 2021-01-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,935,647
Percent of class
10.6300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-001112
Form type
SC 13G/A
Filer
Corbus Pharmaceuticals Holdings, Inc.
CIK
CIK 1595097
Filed
Jan 08, 2021
Reporting period
Jan 07, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub